Treatment of Erythrodermic Psoriasis with Etretinate.
10.5021/ad.1991.3.2.107
- Author:
Bang Soon KIM
;
Ki Shik SHIN
;
Jai Il YOUN
;
Yoo Shin LEE
- Publication Type:Original Article
- Keywords:
Erythrodermic psoriasis;
Etretinate
- MeSH:
Acitretin*;
Cheilitis;
Etretinate*;
Humans;
Psoriasis*;
Weights and Measures
- From:Annals of Dermatology
1991;3(2):107-111
- CountryRepublic of Korea
- Language:English
-
Abstract:
We have investigated the clinical response of 12 patients with erythrodermic psoriasis to therapy with etretinate. Initial dosage of etretinate was 20-60mg/day. The time for complete disappearance of scales averaged 19.9 days. In 10 of 12 patients(83.3%) satisfactory results were obtained after 2 to 11 months of treatment. Cheilitis was the most common side effect. Three patients had mild elevation of blood lipids, which was corrected by dose reduction. Remission period, of ten patients who showed good result, averaged 4.2 months.
